- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
Silver47 Exploration
Purpose Bitcoin ETF
Syntheia
Black Swan Graphene
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Heritage Cannabis Holdings Subsidiary Voyage Receives Sales License from Health Canada
Heritage Cannabis is pleased to announce its subsidiary Voyage has been granted a cannabis oil sales license by Health Canada, effective April 8, 2020.
Heritage Cannabis Holdings Corp. (CSE:CANN) (CNSX.CANN.CN) (OTC:HERTF) (“Heritage” or the “Company”), a leading Canadian cannabis company is pleased to announce that its subsidiary Voyage Cannabis Corp. (“Voyage”) has been granted a cannabis oil sales license by Health Canada, effective April 8, 2020. This sales license will allow Voyage to begin selling cannabis products, including oil derivatives, to the Provincial cannabis boards as well as directly to patients in the medical market. The Company is developing a variety of products which it plans to market under brands that offer unique high quality properties and provide consumers with clear choices.
The Company plans to begin making its cannabis oil available for sale as soon as possible. Included in this offering will be its award-winning, direct-to-vape, all natural oil products. The Company’s proprietary extraction methodology uses high pressure systems and no harmful chemicals. Additionally, Heritage will launch various formulations of full spectrum CBD tinctures when product approval is received from Health Canada.
With the achievement of this sales license, the Company intends to further discussions to create joint ventures with companies which have distinct cannabis products that can be formulated at a Heritage facility and mutually marketed to Canadian consumers.
“We are extremely excited for Voyage to receive this sales license. It is a significant development allowing us to begin selling cannabis oil to the Canadian retail market. We have been processing and formulating products in anticipation of this license and are eager to begin offering them to the public.” stated Clint Sharples, CEO of Heritage. “High quality cannabis oil products are in great demand and we are confident that our customers will appreciate the value in the products we will be bringing to market. Our extraction division, Purefarma, has built a reputation for quality and purity, and this license allows Voyage to offer these products directly to this growing market in addition to our contract manufacturing business.”
About Heritage Cannabis Holdings Corp.
Heritage Cannabis currently has two Health Canada approved licenced producers through its subsidiaries Voyage Cannabis Corp. and CannaCure Corp., both regulated under the Cannabis Act Regulations. Working under these two licences, Heritage has two additional subsidiaries, Purefarma Solutions, which provides extraction services, and a Medical Services Division which is focused on cannabis based medical solutions. Heritage as the parent company, is focused on providing the resources for its subsidiaries to advance their products or services to compete both domestically and internationally.
ON BEHALF OF THE BOARD OF DIRECTORS OF HERITAGE CANNABIS HOLDINGS CORP.
“Clint Sharples”
Clint Sharples
CEO
For more information contact:
Clint Sharples
Tel: 416-705-8529
csharples@heritagecann.com
or
Kelly Castledine
Tel: 647-660-2560
kcastledine@heritagecann.com
The Canadian Stock Exchange does not accept responsibility for the adequacy or accuracy of this release.
This news release contains forward-looking information, which involves known and unknown risks, uncertainties and other factors that may cause actual events to differ materially from current expectation. Important factors – including the availability of funds, the results of financing efforts, the results of exploration activities — that could cause actual results to differ materially from the Company’s expectations are disclosed in the Company’s documents filed from time to time on SEDAR (see www.sedar.com). Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Click here to connect with Heritage Cannabis Holdings Corp. (CSE:CANN) for an Investor Presentation.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.